Paul Calabresi Clinical Oncology Training Program

University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC)

UMGCC’s Paul Calabresi Clinical Oncology Training Program, funded by the National Cancer Institute (NCI), supports tomorrow’s leaders in clinical oncology research through the appointment of Paul Calabresi Scholars (Scholars) following a competitive application process. The award is named for the late Paul Calabresi, M.D., a founder of modern clinical oncology research, who was devoted to mentoring of fellows and junior faculty.

Research Areas

For More Information

The Program will focus primarily on recruitment of Scholars with research interests in three thematic areas:

Multimodality Treatment Strategies for Cancer;
Drug Discovery and Development; and
Underserved Populations & Cancer Treatment Disparities.

Program Resources

The University of Maryland, Baltimore, provides a large number of experienced mentors engaged in a broad range of disciplines, along with the strength of its existing K30 Clinical Research Curriculum for Scholars’ didactic training. The Program receives robust institutional support from UMGCC, as well as University of Maryland, Baltimore.

This page was last updated on: July 3, 2008.